Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novonesis A/S - Adr (NVZMY)
:NVZMY
Earnings Data
Report Date
Feb 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.53Last Year’s EPS
0.37Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: -2.62%
|Next Earnings Date:Feb 26, 2025
Earnings Call Sentiment|Positive
The earnings call indicates a positive overall sentiment with strong organic sales growth, a high number of new product launches, and significant contributions from key segments like Household Care and Advanced Protein Solutions. However, there are challenges such as low growth in Human Health Biosolutions and a flat performance in the Agricultural segment, which are noted as areas needing attention.Company Guidance
In the recent Novonesis conference call discussing the first nine months of fiscal year 2024, the company reported a robust 9% organic sales growth, with volumes increasing by 7% and prices up by approximately 2%. Notably, the third quarter alone witnessed an 11% growth in organic sales. The company launched 29 new solutions, including eight in the third quarter, and expects to achieve organic sales growth at the upper end of the 7% to 8% range for the full year. The adjusted EBITDA margin is projected to be between 35.5% and 36.5%. The leadership emphasized ongoing innovation and synergies, projecting a CAGR increase of over 1% over the next three years. They also highlighted specific growth in divisions like Food & Health Biosolutions and Planetary Health Biosolutions, with particular mention of strong performances in Dairy, Human Health, and Household Care segments.Strong Organic Sales Growth
Novonesis delivered a strong organic sales growth of 9% in the first nine months of 2024, with 11% growth in the third quarter.
Product Launches and Innovation
Novonesis launched 29 solutions in the first nine months, including eight in the third quarter, indicating a high cadence of product innovation.
Growth in Food & Health Biosolutions
Food & Health Biosolutions delivered 8% organic sales growth in the first nine months and 11% in the third quarter, driven by strong performance across subareas.
Household Care Performance
Household Care delivered 15% organic sales growth in the first nine months of 2024, with all regions showing double-digit growth.
Advanced Protein Solutions Contribution
Advanced Protein Solutions showed strong growth and momentum, contributing significantly to Human Health Biosolutions.
---
NVZMY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NVZMY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $58.73 | $61.46 | +4.65% |
| Aug 27, 2024 | $67.35 | $67.94 | +0.88% |
| May 03, 2024 | $55.66 | $59.36 | +6.65% |
| Feb 01, 2024 | $51.34 | $53.68 | +4.56% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Novonesis A/S - Adr (NVZMY) report earnings?
Novonesis A/S - Adr (NVZMY) is schdueled to report earning on Feb 26, 2025, TBA Not Confirmed.
What is Novonesis A/S - Adr (NVZMY) earnings time?
Novonesis A/S - Adr (NVZMY) earnings time is at Feb 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NVZMY EPS forecast?
NVZMY EPS forecast for the fiscal quarter 2024 (Q4) is 0.53.
---